Typical India planning band
Living-donor liver transplant in private Indian hospitals may plan around USD 28,000-55,000+.
India vs Singapore liver transplant planning
Liver transplant cost cannot be judged by the operation alone because the real pathway includes recipient evaluation, donor workup, legal authorization, ethics review, ICU, blood products, biliary or vascular complications, infection control, immunosuppression, nearby recovery, repeat labs, and long-term hepatology follow-up. India is usually more cost-efficient for eligible international self-pay living-donor liver transplant, while Singapore may fit patients with very high budgets and a confirmed legal pathway under Singapore rules.
Short answer for liver transplant families
India is usually lower for eligible self-pay liver transplant when donor workup, recipient optimization, ICU, medicines, recovery stay, caregiver, and follow-up are included. Singapore requires careful legal and hospital-specific confirmation before any quote is meaningful, especially for donor eligibility, allocation rules, foreign-patient pricing, and stay extension.
Use INR, SGD, and USD as planning references only. Refresh INR through FBIL and SGD through MAS before deposits because ICU duration, blood products, donor workup, infection care, immunosuppressants, and exchange settlement can change final bills.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-08-25
Clinical review: Virello Health transplant review team · Editorial review: Virello Health medical travel editorial team
Reviewed for living donor consent, transplant authorization, NOTTO and Singapore HOTA/MTERA boundaries, India medical visa, Singapore STVP extension, and post-transplant immunosuppression continuity.
Living-donor liver transplant in private Indian hospitals may plan around USD 28,000-55,000+.
Singapore private liver transplant planning may exceed USD 2,00,000 when ICU and medicines are included.
Donor relationship, authorization, consent, allocation, and hospital acceptance must be checked before travel.
Liver tests, infection watch, rejection review, and lifelong immunosuppression continue after travel.
Side-by-side view
Use this table to check whether two quotes are describing the same patient pathway before comparing the final number.
| Factor | India | Singapore | Patient note |
|---|---|---|---|
| Best cost fit | Often stronger for eligible self-pay living-donor transplant. | Only realistic with confirmed legal route and very high private budget. | Legal clearance first. |
| Donor pathway | Authorization committee and NOTTO rules need documented relationship and consent. | Singapore HOTA/MTERA and hospital policy require separate legal confirmation. | No informal donor claims. |
| ICU reserve | Lower ICU and blood-product cost helps high-risk patients. | Singapore ICU is premium priced. | Ask extra-day rates. |
| Complication care | Biliary, vascular, infection, or rejection care can be budgeted with lower stay costs. | Singapore complications can sharply increase final private bills. | Reserve is mandatory. |
| Caregiver stay | Longer recipient and donor recovery is usually more affordable. | Singapore lodging and caregiver support are expensive. | Count both patient and donor. |
| Follow-up | Home hepatology handover must include medicine levels and warning signs. | Same handover is needed after Singapore care. | No medicine gap. |
| Travel documents | Medical visa and donor documents must align. | STVP extension may be needed for recovery or complications. | Plan longer stay. |
Read the estimate
Diagnosis, MELD, infection, cancer status, heart fitness, and nutrition must be reviewed before pricing.
Relationship, consent, donor fitness, ethics review, and country rules must be documented.
Donor evaluation, donor surgery, recipient surgery, ICU, medicines, and lodging should be itemized.
Bleeding, biliary leak, vascular issue, infection, kidney injury, or rejection can extend care.
Immunosuppressants, drug-level tests, liver tests, and infection prevention continue after discharge.
Clinical scope
A healthy donor gives part of the liver after strict medical and legal evaluation.
Allocation rules differ by country and should not be assumed available for foreign patients.
Ascites, infection, bleeding risk, nutrition, kidney function, and heart fitness influence timing.
Donor liver volume, anatomy, mental readiness, and independent consent are essential.
Rejection monitoring, infection prevention, medicine levels, diet, and hepatology follow-up are lifelong.
When India may fit
India often fits families with a medically suitable, legally acceptable donor and self-pay budget constraints.
Lower lodging and follow-up costs support longer stay for donor and recipient recovery.
Delhi NCR, Chennai, Mumbai, Hyderabad, Bengaluru, and Kochi can be compared by program depth.
Indian teams can prepare detailed discharge records for home hepatology follow-up.
When Singapore may fit
Singapore may fit if private transplant, ICU, medicines, and lodging are affordable.
Singapore should be considered only after hospital and legal eligibility are confirmed.
Some families may value Singapore governance and specialist access despite cost.
Nearby families may prefer Singapore when travel distance and support are favorable.
Cost comparison
| Hospital package | India local | India USD | SGD | Comparator USD | Scope |
|---|---|---|---|---|---|
| Recipient and donor evaluation | INR 4,00,000-10,00,000 | USD 4,800-12,000 | SGD 25,000-90,000 | USD 19,230-69,230 | Labs, imaging, donor volume, cardiac checks, infection screen, legal review, and counseling. |
| Living-donor liver transplant | INR 24,00,000-46,00,000 | USD 28,800-55,200 | SGD 2,50,000-5,50,000+ | USD 1,92,310-4,23,080+ | Donor surgery, recipient transplant, anesthesia, ICU, ward, blood, medicines, and early review. |
| High-risk or complicated course | INR 40,00,000-80,00,000+ | USD 48,000-96,000+ | SGD 4,50,000-9,00,000+ | USD 3,46,155-6,92,310+ | MELD risk, infection, kidney support, prolonged ICU, reoperation, rejection, or biliary complication. |
| Extended care | India local | India USD | SGD | Comparator USD | Scope |
|---|---|---|---|---|---|
| Donor workup add-ons | INR 1,50,000-5,00,000 | USD 1,800-6,000 | SGD 10,000-45,000 | USD 7,690-34,615 | CT volumetry, liver anatomy, labs, mental health, independent donor counseling, and repeat tests. |
| Extra ICU or organ support | INR 80,000-4,00,000/day | USD 960-4,800/day | SGD 6,000-28,000/day | USD 4,615-21,540/day | Ventilation, dialysis, bleeding, infection, sepsis, or graft dysfunction. |
| Immunosuppression month | INR 40,000-2,50,000 | USD 480-3,000 | SGD 2,500-18,000 | USD 1,925-13,850 | Tacrolimus or equivalent, prophylaxis, drug levels, labs, and infection prevention. |
| Follow-up quarter | INR 1,00,000-5,00,000 | USD 1,200-6,000 | SGD 8,000-45,000 | USD 6,155-34,615 | Liver tests, scans, biopsy if needed, rejection review, donor follow-up, and hepatology visits. |
| Complete trip budget | India local | India USD | SGD | Comparator USD | Scope |
|---|---|---|---|---|---|
| Flights for donor and recipient | Origin dependent | USD 700-4,000+ | Origin dependent | USD 350-3,200+ | Two travelers plus attendants may need flexible medical tickets. |
| Visa or STVP extension | Nationality dependent | Varies | SGD 40+ when extension applies | USD 30+ | Transplant recovery often exceeds simple short-stay assumptions. |
| Long recovery lodging | INR 4,000-18,000/night | USD 48-215/night | SGD 180-750/night | USD 138-575/night | Donor and recipient may need separate recovery support near hospital. |
| Caregiver support | INR 3,000-12,000/day | USD 36-145/day | SGD 120-400/day | USD 92-310/day | Medicine timing, infection control, diet, wound care, and transport. |
| Local transport | INR 1,500-7,000/visit | USD 18-85/visit | SGD 60-320/visit | USD 46-245/visit | Frequent labs, hepatology visits, scans, and donor checks. |
| Diet and hygiene | INR 2,500-9,000/day | USD 30-110/day | SGD 100-350/day | USD 77-270/day | High-protein food, safe water, masks, sanitizers, and wound supplies. |
| Delay reserve | 25-45% of care budget | Reserve in USD | 35-60% of care budget | Reserve in USD | Infection, rejection, bile leak, kidney support, or donor issue can extend stay. |
| Home transplant follow-up | Home pricing | Varies | Home pricing | Varies | Drug levels, liver tests, infection care, vaccines, and emergency hepatology. |
Usually included
MELD, diagnosis, infection, cancer status, heart fitness, kidney function, and nutrition should be listed.
Eligibility.
Relationship, liver volume, anatomy, labs, mental readiness, and independent consent should be documented.
Donor safety.
Committee review, affidavits, identity papers, and hospital legal process should be visible.
Mandatory.
Donor surgery, recipient transplant, surgeon, anesthesia, operation room, and blood products should be stated.
Core quote.
Included ICU, ward, donor stay, recipient stay, and extra-day charges should be clear.
Cost driver.
Immunosuppression, antibiotics, antivirals, antifungals, pain medicines, and prophylaxis should be listed.
Long-term.
Isolation, visitor rules, food safety, and fever pathway should be explained.
Safety.
Operation notes, donor summary, labs, medicine list, warning signs, and follow-up calendar should come home.
Continuity.
Confirm separately
Unrelated or unclear donor claims must not be priced without legal review.
High risk.
Access to deceased donor organs for foreign patients cannot be assumed.
Verify law.
Sepsis, bleeding, kidney support, graft dysfunction, or ventilation can add daily charges.
Reserve.
Bleeding, vascular, or bile duct complications may need additional procedures.
Not routine.
Biopsy, steroids, antibody therapy, or admission may be separate.
Monitor.
Donor bile leak, pain, infection, or readmission may add cost.
Donor included.
Resident or public figures should not be treated as international private transplant quotes.
Private quote.
Lifelong immunosuppressants and lab monitoring continue outside the hospital quote.
Plan home.
Cost drivers
MELD, infection, bleeding, kidney disease, cancer status, and malnutrition affect risk.
Optimize.
Liver volume, vessel anatomy, fat content, and donor health influence surgery.
CT needed.
Relationship proof and authorization steps can add time and travel cost.
Start early.
Ventilation, kidney support, sepsis, bleeding, or graft dysfunction changes cost.
Reserve.
Transplant can require significant blood and plasma support.
Ask policy.
Surgeon, hospital, ICU, blood, medicines, GST, and donor fees need itemization.
Breakup.
Brand, dose, drug-level testing, and infection prophylaxis affect monthly cost.
Lifelong.
Recipient or donor complications can delay return by weeks.
Flexible stay.
Hospital selection
Confirm hospital transplant authorization and donor acceptance pathway before travel.
No shortcut.
Recipient evaluation needs hepatology, transplant surgery, ICU, infectious disease, and radiology.
Team care.
Independent donor counseling, volume analysis, and donor follow-up should be clear.
Donor first.
Transplant ICU, blood bank, dialysis backup, and emergency reoperation access are essential.
Risk safety.
Isolation, visitor rules, fever pathway, and prophylaxis should be written.
Immunosuppressed.
Donor and recipient costs, extra ICU, medicines, and reoperation should be separated.
Avoid surprise.
Drug-level plan, lab calendar, donor summary, and home hepatology handover are required.
Continuity.
Treating team
Choose a surgeon who explains donor and recipient risks, graft plan, and complication pathway.
The hepatologist should review disease severity, cancer status, infection, and lifelong follow-up.
Donor counseling should be independent and focused on donor safety.
Infection prevention and fever response are central after transplant.
A local hepatologist must be ready for drug levels, labs, and emergency review.
Patient journey
Upload diagnosis, MELD labs, scans, endoscopy, infection history, medicines, and admissions.
Check blood group, relationship documents, basic health, willingness, and travel ability.
Ask hospital to explain India or Singapore donor authorization steps in writing.
Separate donor workup, donor surgery, recipient surgery, ICU, medicines, and exclusions.
Treat infection, nutrition, ascites, kidney risk, diabetes, dental issues, and vaccines where appropriate.
Stay until labs, wound, medicine levels, donor health, and infection risk are stable.
Arrange home hepatology, drug levels, labs, vaccines, diet, and emergency pathways.
Recipient and donor need transplant-team clearance before flights.
Both matter.
Identity, relationship, affidavits, consent, and committee timing should be planned.
No last minute.
Expect repeat labs, imaging, infection tests, donor CT, and counseling.
Quote may update.
Track graft function, bleeding, infection, kidney support, and ventilation.
Daily updates.
Use low-infection lodging close to hospital with safe food and transport.
High caution.
Fly after labs, wound, infection risk, medicines, and donor recovery are stable.
Written clearance.
Book hepatology and lab monitoring before leaving destination.
No gap.
Use NOTTO and authorized hospital guidance for living donor documentation and foreign patient review.
HOTA/MTERA and hospital policy must be checked before assuming donor or organ availability.
Use India e-Visa guidance and Singapore STVP extension rules for patient, donor, and attendants.
Recipient and donor consent should cover death, graft failure, infection, bleeding, rejection, and donor harm.
Safety and risks
Any payment or coercion concern should stop planning immediately.
Legal danger.
Sepsis, bleeding, encephalopathy, kidney failure, or ICU need may make travel unsafe.
Stabilize.
Donor surgery has real risks and must be independently consented.
Donor first.
Abnormal labs can appear before symptoms and need urgent review.
Monitor labs.
Immunosuppression increases infection risk and can hide symptoms.
Fever plan.
Missing immunosuppressants can endanger the graft.
Stock supply.
ICU, reoperation, dialysis, infection, or rejection can multiply costs.
High reserve.
Recovery and continuity
Plan tacrolimus or equivalent levels and dose changes with a transplant doctor.
Track bilirubin, INR, enzymes, albumin, kidney function, and blood counts.
Donor wound, pain, liver tests, diet, and emotional recovery need review.
Follow food safety, hygiene, crowd avoidance, and fever instructions.
Confirm immunosuppressant supply and brands are available at home.
Know where to go for fever, jaundice, confusion, vomiting, bleeding, or reduced urine.
Carry operative notes, donor summary, labs, medicines, imaging, and follow-up schedule.
Decision guide
India may fit when legal documents are strong and total budget matters.
Singapore may fit only when legality, hospital acceptance, and high private cost are confirmed.
Travel may be unsafe if infection, bleeding, encephalopathy, or kidney failure is uncontrolled.
| Factor | India may fit when | Singapore may fit when | Verify before booking |
|---|---|---|---|
| Legal route | NOTTO and hospital authorization are feasible. | Singapore hospital confirms legal acceptance. | Written pathway. |
| Donor safety | Donor workup and consent are clear. | Donor review fits Singapore policy. | Donor file. |
| Cost reserve | Lower ICU and stay cost matters. | Very high reserve is available. | Itemized quote. |
| Complications | Longer nearby recovery is affordable. | Premium complication care is affordable. | Extra-day rates. |
| Follow-up | Home hepatologist can continue labs. | Singapore handover is complete. | Lab calendar. |
| Documents | Medical visa covers patient and donor needs. | STVP extension plan is ready. | Entry timeline. |
Reports and questions
Share liver disease cause, MELD labs, scans, endoscopy, infection history, and admissions.
Include tumor markers, liver imaging, biopsy if any, and oncology notes.
Provide blood group, age, relationship, health history, willingness, and identity documents.
Include heart, lung, kidney, diabetes, nutrition, dental, and vaccination history.
List diuretics, lactulose, antivirals, antibiotics, blood thinners, and allergies.
Share TIPS, banding, paracentesis, surgery, ICU, and transfusion records.
Prepare relationship proof, passports, affidavits, and consent records as advised.
State origin, caregiver, donor travel, budget, visa status, and urgency.
Ask hospital to confirm the donor category before travel.
Request CT volumetry, labs, counseling, and repeat-test policy.
Confirm donor and recipient included days and extra-day rates.
Ask blood, plasma, platelets, and cell-saver policy.
Clarify dialysis, infection, reoperation, rejection, and biliary procedure charges.
Ask immunosuppressants, prophylaxis, drug levels, and first-month supply.
Check visa or STVP extension support for patient, donor, and attendants.
Request operative notes, donor summary, labs, medicine list, and follow-up calendar.
Ask how MELD, infection, kidney function, nutrition, and heart risk affect timing.
Ask donor risk, liver volume, anatomy, and independent consent details.
Ask each step and document required before surgery can happen.
Discuss infection, rejection, bile leak, kidney support, and donor recovery.
Ask drug-level schedule, side effects, and home availability.
Ask separate clearance criteria for donor and recipient.
Related guidance
Common questions
India is usually much lower for eligible self-pay living-donor transplant after ICU, donor workup, medicines, lodging, and follow-up are counted.
No. Donor relationship, medical fitness, consent, legal authorization, and hospital acceptance must be verified.
Do not assume this. Singapore organ allocation and hospital policies need direct legal and clinical confirmation.
Recipient severity, donor anatomy, ICU days, blood products, infection, rejection, kidney support, and complications.
Recipient diagnosis, MELD labs, scans, endoscopy, infection history, donor documents, medicines, and fitness reports.
Stay depends on graft function, infection risk, medicine levels, donor recovery, labs, and flight clearance.
ICA may require doctor-endorsed documents for medical-treatment stay extension.
Most transplant recipients need long-term immunosuppression and regular monitoring.
Unverified donor legality, infection, rejection, bleeding, graft dysfunction, and medicine interruption are major risks.
Virello can organize reports, check missing legal and clinical items, and coordinate itemized India and Singapore estimates.
Method and sources
This liver transplant comparison separates recipient fitness, donor safety, legal authorization, HOTA/MTERA and NOTTO boundaries, ICU and blood-product assumptions, immunosuppression, infection control, Singapore private-fee context, STVP extension, India medical visa, MAS and FBIL currency references, and lifelong handover. Email support@virellohealth.com for report-led support.
Need a report-led comparison?
Virello Health can help organize the case summary, quote questions, hospital scope, and practical next steps. For written communication, use support@virellohealth.com.